Written by Admin | Jul 5, 2023 4:00:00 AM
Dr. Mike Montalto, PhD, PathAI Chief Scientific Officer, explores the potential of artificial intelligence to standardize the analysis of tumor microenvironment (TME) which will enable researchers to better understand treatment pathways, identify novel biomarkers, and advance drug development. Mike Montalto